Inspira develops a cost-effective minimally invasive Extracorporeal Respiratory Support technology (ECRS), which the company believes has the potential to utilize oxygen to rebalance patients' saturation levels while they are awake. Inspira's technology has the potential to prevent the need for mechanical ventilation.